7
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Section Review: The rate-limiting step in obtaining human monoclonal antibody drug pharmaceuticals:Biologicals & Immunologicals

&
Pages 225-228 | Published online: 03 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mark C Glassy & Michael E McKnight. (2005) Requirements for human antibody cocktails for oncology. Expert Opinion on Biological Therapy 5:10, pages 1333-1338.
Read now
Mark C Glassy & Keiji Koda. (2002) The nature of an ideal therapeutic human antibody. Expert Opinion on Biological Therapy 2:1, pages 1-2.
Read now
Mark C Glassy, Jun Yasutomi & Keiji Koda. (1999) Lessons learned about the therapeutic potential of the natural human immune response to lung cancer. Expert Opinion on Investigational Drugs 8:7, pages 995-1006.
Read now
Michael E McKnight & Mark C Glassy. (1995) Monthly Update: Biologicals & Immunologicals: The autoimmunity of cancer as applied to drug development. Expert Opinion on Investigational Drugs 4:7, pages 657-661.
Read now

Articles from other publishers (1)

Sumit Goswami, Wei Wang, Tsutomu Arakawa & Satoshi Ohtake. (2013) Developments and Challenges for mAb-Based Therapeutics. Antibodies 2:4, pages 452-500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.